KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) FCF Margin (2016 - 2026)

AbbVie has reported FCF Margin over the past 14 years, most recently at 29.42% for Q4 2025.

  • Quarterly FCF Margin fell 1532.0% to 29.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 29.13% through Dec 2025, down 252.0% year-over-year, with the annual reading at 29.13% for FY2025, 252.0% down from the prior year.
  • FCF Margin was 29.42% for Q4 2025 at AbbVie, down from 42.11% in the prior quarter.
  • Over five years, FCF Margin peaked at 53.81% in Q3 2021 and troughed at 10.49% in Q1 2025.
  • The 5-year median for FCF Margin is 34.35% (2021), against an average of 36.2%.
  • Year-over-year, FCF Margin crashed -3025bps in 2024 and then surged 1763bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 32.84% in 2021, then skyrocketed by 45bps to 47.72% in 2022, then crashed by -33bps to 31.8% in 2023, then skyrocketed by 41bps to 44.74% in 2024, then plummeted by -34bps to 29.42% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's FCF Margin are 29.42% (Q4 2025), 42.11% (Q3 2025), and 31.67% (Q2 2025).